Serum fibrinogen level predicts the therapeutic response and prognosis in patients with locally advanced rectal cancer

Hepato-Gastroenterology

Volumn 58, Issue 110-111, 2011, Pages 1507-1510

  Lu, Ke ^a,b   Zhu, Yuan ^b   Sheng, Liming ^b   Liu, Luying ^b   Shen, Li ^a   Wei, Qichun ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Chemoradiotherapy; Locally advanced rectal cancer; Prognosis; Serum fibrinogen

Indexed keywords

FIBRINOGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPARATIVE STUDY; CONTINUOUS INFUSION; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; FOLLOW UP; HUMAN; HYPERFIBRINOGENEMIA; HYPOFIBRINOGENEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT RESPONSE;

EID: 83355169845     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11133     Document Type: Article

References (15)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-249.
2. Roh MS, Colangelo LH, O'Connell MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ, Wolmark N: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. Clin Oncol 2009; 27:5124-5130.
3. Kuremsky JG, Tepper JE, McLeod HL: Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2009; 74:673-688.
4. Staton CA, Brown NJ, Lewis CE: The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin Biol Ther 2003; 3:1105-1120. (Pubitemid 37295766)
5. Yamashita H, Kitayama J, Kanno N, Yatomi Y, Nagawa H: Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer 2006; 6: 147.
6. Takeuchi H, Ikeuchi S, Kitagawa Y, Shimada A, Oishi T, Isobe Y, Kubochi K, Kitajima M, Matsumoto S: Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroenterol Hepatol 2007; 22:2222-2227. (Pubitemid 350145609)
7. Polterauer S, Grimm C, Seebacher V, Concin N, Marth C, Tomovski C, Husslein H, Leipold H, Hefler-Frischmuth K, Tempfer C, Reinthaller A, Hefler L: Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. Oncologist 2009; 14:979-985.
8. Jones JM, McGonigle NC, McAnespie M, Cran GW, Graham AN: Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer. Lung Cancer 2006; 53:97-101. (Pubitemid 43831357)
9. Guo Q, Zhang B, Dong X, Xie Q, Guo E, Huang H, Wu Y: Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor. Pancreas 2009; 38:75-79.
10. Song SW, Lee HS, Kim MS, Lee JM, Kim JH, Nam BH, Zo JI: Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection. Ann Thorac Surg 2006; 81:1974-1981. (Pubitemid 43775531)
11. Yamashita H, Kitayama J, Taguri M, Nagawa H: Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response. World J Surg 2009; 33:1298-1305.
12. Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, Bugge TH: Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000; 96:3302-3309.
13. Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW: Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost 2008; 6:176-183.
14. Gérard JP, Azria D, Gourgou-Bourgade S, Martel-Laffay I, Hennequin C, Etienne PL, Vendrely V, François E, de La Roche G, Bouché O, Mirabel X, Denis B, Mineur L, Berdah JF, Mahé MA, Bécouarn Y, Dupuis O, Lledo G, Montoto-Grillot C, Conroy T: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010; 28(10):1638-1644.
15. Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupattelli M, Favretto MS, La Torre G: Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008; 72:99-107.